Ali health: to hand over the drug electronic supervision network to the State Food and Drug Administration
-
Last Update: 2016-02-22
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: techweb news on February 22, 2016, Ali health released a notice through the Hong Kong stock exchange, disclosing "inside information about the future operation and maintenance of drug electronic regulatory network business", saying that it is discussing the transfer of drug electronic regulatory network with the State Food and drug administration Alibaba health announcement: Alibaba health announcement will be transferred to the State Food and drug administration, pointing out that "Alibaba health is entrusted by the State Food and drug administration as the technical operator of the drug electronic regulatory network, only providing technology and maintenance services, not the owner of the drug electronic regulatory network, and the ownership of the drug electronic regulatory network has always been owned by the State Food and Drug Administration" Since the announcement of clarification to the outside world was released on January 28, Ali health "has further discussed the matter with the State Food and drug administration, and set up a joint working group to discuss the transfer of the drug electronic regulatory network The handover details (including schedule and operation and maintenance business mode during the period) still need to be further confirmed " At the same time, Ali Health said that it has not yet received a notice from the State Food and drug administration to stop the technology and operation and maintenance services of the drug electronic regulatory network Before that, there was a rumor in the industry that the State Food and Drug Administration withdrew Ali health's right to operate the drug electronic regulatory network This is due to the event that Hunan yangtianhe pharmacy sued the State Food and Drug Administration for nearly a month January 26 this year Hunan yangtianhe pharmacy announced that it would take the State Food and drug administration to court on Tuesday, believing that the enforcement of drug electronic supervision code by the State Food and drug administration is suspected of being illegal Without disclosing standards and procedures to the public, the operation of drug electronic supervision network is entrusted to Ali health for exclusive operation, which not only violates the provisions of the bidding law, but also is suspected of administrative monopoly Two days later, Ali Health issued a clarification announcement that: the company is the entrusted technology operator of the drug electronic regulatory network, not the owner of the drug electronic regulatory network, because the ownership of the drug electronic regulatory network has always been owned by the State Food and drug administration The company only provides technical support and maintenance services On February 20, the State Food and Drug Administration (CFDA) issued the announcement on suspending the implementation of relevant matters concerning the full implementation of drug electronic supervision by drug manufacturing and trading enterprises On the evening of the 21st, Ali Health announced again that since the release of the Clarification Announcement, Ali health and CFDA have further discussed the matter and set up a joint working group to discuss the transfer of the drug electronic regulatory network Alibaba health is a comprehensive healthcare information and content service provider under Alibaba Through the backdoor "CITIC 21 century", Alibaba health has successfully listed on the Hong Kong stock exchange Its main business includes three items: first, operation and maintenance of drug electronic regulatory network; second, construction of medical service network; third, medical e-commerce business In addition, alihealth has added health insurance business It is reported that Alibaba originally planned to transfer tmall Pharma, China's largest third-party Internet drug retail platform, to Alibaba health, and planned to complete the transaction by the end of 2015, but it was actually delayed On January 4, 2016, Ali Health issued a notice to extend the acquisition of tmall global medical center to a later date before March 31, 2016 or as agreed by both parties.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.